When the previous results were put together, it was found that hepatic NPC1L1 has no effect on the risk of CGD on HFCD and LD diets, while EZE can stop the intestinal absorption of cholesterol and prevent CGD. The gene discussed is NPC1L1; the disease is chronic granulomatous disease.